• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natural Capsules Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4124.0
  • ISIN : INE936B01015
220.77 -3 (-1.37%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    218.00

  • Today’s High

    228.00

  • Open

    228.00

  • Perv Close

    223.83

  • 52W Low

    164.00

  • 52W High

    274.75

Key Indicators

  • P/E(TTM)

    34.07

  • Mar.Cap (₹Cr.)

    228.30

  • Div & Yield %

    0.00

  • Book Value(₹)

    160.83

  • Debt-Equity Ratio

    -1.37

  • AGM Date

    11-Jul-2025

  • EPS

    6.49

  • P/E Ratio

    34.07

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    228.30

  • RONW (%)

    3.39

  • ROCE (%)

    5.00

Score Board

  • Equity (₹ in Cr.)

    10.34

  • BV (₹)

    160.80

  • Sales( ₹ in Cr.)

    167.94

  • NP (in Cr.)

    6.71

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    14.50

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    228.64

  • 52 Week High

    274.75

  • 52 Week Low

    164.00

  • Price BSE

    221.0

  • Price NSE

    221.00

  • Market Capital( in Cr.)

    228.64

  • P/C Ratio

    15.20

  • P/E Ratio

    34.10

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 153.81 172.87 135.07 79.51 61.55 59.78
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 153.81 172.87 135.07 79.51 61.55 59.78
Other Income 3.15 1.07 0.93 2.90 0.95 1.14
Stock Adjustments 6.13 5.18 -1.81 -1.33 -0.11 -3.69
Total Income 163.09 179.12 134.19 81.08 62.39 57.23
EXPENDITURE :            
Raw Materials 83.32 84.14 57.99 36.10 27.92 22.80
Power and Fuel Cost 15.19 13.75 11.90 8.51 8.16 8.89
Employee Cost 10.95 9.51 8.48 6.97 5.91 5.57
Other Manufacturing Expenses 12.58 11.79 7.57 4.45 4.53 4.59
Selling and Administration Expenses 17.20 22.86 16.87 9.73 8.99 8.89
Miscellaneous Expenses -0.20 0.24 4.83 1.29 0.49 0.69
Employee Benefit Expenses 10.95 9.51 8.48 6.97 5.91 5.57
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 139.04 142.30 107.64 67.05 56.00 51.43
Operating Profit 24.05 36.82 26.54 14.04 6.40 5.80
Interest 5.09 3.88 2.08 0.54 0.91 0.53
Gross Profit 18.96 32.94 24.46 13.50 5.49 5.27
Depreciation 8.57 7.20 5.04 4.31 4.12 3.20
Profit Before Tax 10.39 25.74 19.42 9.19 1.37 2.07
Current Tax 1.97 5.46 4.74 2.22 0.66 0.79
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.62 1.09 0.73 0.02 -0.14 -0.65
Reported Net Profit 7.81 19.20 13.95 6.95 0.86 1.92
Extraordinary Items 0.00 0.03 0.05 1.65 0.00 -0.22
Adjusted Net Profit 7.81 19.17 13.90 5.30 0.86 2.14
Adjustment below Net Profit 0.00 0.00 -0.20 -0.06 -0.11 -0.13
P & L Balance brought forward 74.29 55.86 42.73 36.22 36.09 34.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.93 0.77 0.62 0.37 0.62 0.62
P & L Balance carried down 81.16 74.29 55.86 42.73 36.22 36.09
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 10.00 10.00 10.00 6.00 10.00
Dividend Per Share(Rs) 0.00 1.00 1.00 1.00 0.60 1.00
Earnings Per Share-Unit Curr 8.36 20.70 19.90 11.15 1.38 3.08
Earnings Per Share(Adj)-Unit Curr 8.36 20.70 19.90 9.14 1.13 2.53
Book Value 141.30 133.74 118.45 99.68 89.24 89.04
Book Value(Adj)-Unit Curr 141.30 133.74 118.45 81.74 73.18 73.01

Shareholding Pattern

  • Promoter Group

    51.21%

  • Public Share Holding

    48.79%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,172,854 21.01 2,172,854 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,261 0.02 1,861 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,120,633 30.18 3,120,633 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,295,748 51.21 5,295,348 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,032,855 9.99 1,031,455 68
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 156,675 1.52 151,075 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 150,000 1.45 150,000 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 846,477 8.19 846,477 12
Individuals holding nominal share capital up to Rs. 1 lakh 2,575,294 24.90 2,477,669 8,966
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 284,105 2.75 284,105 206
Sub Total 5,045,406 48.79 4,940,781 9,406
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,341,154 100.00 10,236,129 9,425

Company Background

Natural Capsules LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natural Capsules Ltd
  • BSE Code : 4124.0
  • ISIN : INE936B01015

  • Incorporation Year

    1993

  • Registered Office

    Trident Towers 4th Floor No 23
    100Feet Road Jayanagar IIBlock, Bangalore,
    Karnataka-560011

  • Telephone

    91-080-26671571/26671573/26671581

  • FAX

    91-080-26671562

  • Chairman

    C P Rangachar

  • Managing Director

    Sunil L Mundra

  • Company Secretary

  • Auditor

    P Chandrasekar LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Natural Capsules Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natural Capsules 221.10 156.95 153.81 34.07 8.43
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10